As of 2026-09-11, the Relative Valuation of Edgewise Therapeutics Inc (EWTX) is (47.66) USD. This relative valuation is based on P/E multiples. With the latest stock price at 43.39 USD, the upside of Edgewise Therapeutics Inc based on Relative Valuation is -209.8%.
The range of the Relative Valuation is (38.05) - (39.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.8x - 34.1x | 30.6x |
| Forward P/E multiples | 17.9x - 21.7x | 21.4x |
| Fair Price | (38.05) - (39.78) | (47.66) |
| Upside | -187.7% - -191.7% | -209.8% |
| Date | P/E |
| 2026-09-04 | -23.50 |
| 2026-09-03 | -22.88 |
| 2026-09-02 | -22.90 |
| 2026-09-01 | -23.05 |
| 2026-08-31 | -22.79 |
| 2026-08-28 | -23.33 |
| 2026-08-27 | -24.11 |
| 2026-08-26 | -24.21 |
| 2026-08-25 | -24.12 |
| 2026-08-24 | -24.40 |
| 2026-08-21 | -24.10 |
| 2026-08-20 | -23.62 |
| 2026-08-19 | -25.33 |
| 2026-08-18 | -24.06 |
| 2026-08-17 | -24.03 |
| 2026-08-14 | -24.10 |
| 2026-08-13 | -23.56 |
| 2026-08-12 | -23.76 |
| 2026-08-11 | -24.17 |
| 2026-08-10 | -24.32 |
| 2026-08-07 | -23.74 |
| 2026-08-06 | -24.23 |
| 2026-08-05 | -24.54 |
| 2026-08-04 | -24.39 |
| 2026-08-03 | -20.94 |
| 2026-07-31 | -20.96 |
| 2026-07-30 | -22.43 |
| 2026-07-29 | -21.68 |
| 2026-07-28 | -22.01 |
| 2026-07-27 | -22.69 |
| 2026-07-24 | -22.28 |
| 2026-07-23 | -21.43 |
| 2026-07-22 | -20.91 |
| 2026-07-21 | -21.59 |
| 2026-07-20 | -21.17 |
| 2026-07-17 | -21.69 |
| 2026-07-16 | -20.83 |
| 2026-07-15 | -22.27 |
| 2026-07-14 | -21.67 |
| 2026-07-13 | -22.51 |
| 2026-07-10 | -24.77 |
| 2026-07-09 | -26.38 |
| 2026-07-08 | -25.26 |
| 2026-07-07 | -23.53 |
| 2026-07-06 | -21.88 |
| 2026-07-02 | -21.58 |
| 2026-07-01 | -21.36 |
| 2026-06-30 | -22.16 |
| 2026-06-29 | -22.32 |
| 2026-06-26 | -22.62 |